Variant report
Variant | nsv523139 |
---|---|
Chromosome Location | chr3:554312-565961 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:556350..557928-chr3:558208..559835,2 | MCF-7 | breast: | |
2 | chr3:554700..557337-chr3:557649..560284,2 | K562 | blood: | |
3 | chr3:556350..557928-chr3:558208..559835,2 | MCF-7 | breast: | |
4 | chr3:554700..557337-chr3:557649..560284,2 | K562 | blood: | |
5 | chr3:565796..568589-chr3:571178..572728,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147396393 | chr3:554620-554621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77512511 | chr3:554629-554630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536367381 | chr3:554673-554674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549311832 | chr3:554678-554679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191479398 | chr3:554684-554685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529529009 | chr3:554762-554763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182411997 | chr3:554765-554766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187076539 | chr3:554773-554774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528172048 | chr3:554804-554805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9311442 | chr3:554818-554819 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs375897664 | chr3:554850-554851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537865973 | chr3:554859-554860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549604664 | chr3:554877-554878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192801327 | chr3:554920-554921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185254174 | chr3:554932-554933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563349343 | chr3:554954-554955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116209851 | chr3:554956-554957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554317420 | chr3:554970-554971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190034609 | chr3:554999-555000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550392601 | chr3:555020-555021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9822336 | chr3:555051-555052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138025153 | chr3:555063-555064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577096930 | chr3:555079-555080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547655466 | chr3:555081-555082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76858943 | chr3:555091-555092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536605995 | chr3:555128-555129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143475328 | chr3:555146-555147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs33997719 | chr3:555161-555162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9883014 | chr3:555184-555185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs537139643 | chr3:555189-555190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551811681 | chr3:555195-555196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368246455 | chr3:555234-555235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111415752 | chr3:555237-555238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577085545 | chr3:555316-555317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147166020 | chr3:555327-555328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553263398 | chr3:555391-555392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574353139 | chr3:555410-555411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140340469 | chr3:555446-555447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576026087 | chr3:555455-555456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374490229 | chr3:555462-555463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs193210098 | chr3:555500-555501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115948390 | chr3:555512-555513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568397123 | chr3:555569-555570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532531616 | chr3:555593-555594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543840699 | chr3:555594-555595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546057517 | chr3:555711-555712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559570313 | chr3:555726-555727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530324423 | chr3:555733-555734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548603134 | chr3:555734-555735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569933316 | chr3:555773-555774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 20685689 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:554600-556200 | Enhancers | Hela-S3 | cervix |
2 | chr3:554600-556400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr3:554800-556400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr3:555400-556400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr3:556000-556400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr3:560600-561200 | Enhancers | Fetal Lung | lung |
7 | chr3:561200-562200 | Weak transcription | Fetal Lung | lung |
8 | chr3:562600-562800 | Enhancers | Fetal Lung | lung |
9 | chr3:563400-564600 | Weak transcription | Aorta | Aorta |
10 | chr3:564200-564800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr3:564600-564800 | Enhancers | Aorta | Aorta |